Sarkar F H, Gupta S L
Proc Natl Acad Sci U S A. 1984 Aug;81(16):5160-4. doi: 10.1073/pnas.81.16.5160.
Purified recombinant human gamma interferon (HuIFN-gamma), labeled with 125I (125I-HuIFN-gamma), was used to study receptors for HuIFN-gamma on human WISH cells. 125I-HuIFN-gamma was bound to WISH cells, and this binding was displaced by unlabeled HuIFN-gamma but not by unlabeled recombinant HuIFN-alpha 2 or [Ser17]HuIFN-beta (HuIFN-beta with serine substituted for cysteine at position 17), indicating the presence of specific binding sites for HuIFN-gamma. The cell-bound 125I-HuIFN-gamma was crosslinked with disuccinimidyl suberate or ethylene glycol bis(succinimidyl succinate), which yielded a complex of Mr approximately 105,000 +/- 5000 as analyzed by NaDodSO4/PAGE. The formation of this complex was prevented by preincubation of cells with unlabeled HuIFN-gamma but not with HuIFN-alpha 2 or [Ser17]HuIFN-beta, indicating that HuIFN-gamma binds to a specific receptor molecule and that HuIFN-alpha 2 or HuIFN-beta do not interact with this receptor. Experiments were carried out with 125I-labeled recombinant [Ser17]HuIFN-beta (125I-[Ser17]HuIFN-beta) to verify this conclusion. Binding and crosslinking of 125I-[Ser17]HuIFN-beta to human WISH cells and Daudi cells yielded a complex of Mr approximately 150,000 similar to that obtained with 125I-HuIFN-alpha 2 as described earlier. The formation of this Mr 150,000 complex with 125I-[Ser17]HuIFN-beta was displaced by unlabeled [Ser17]HuIFN-beta and by HuIFN-alpha 2 but not by HuIFN-gamma, indicating that [Ser17]HuIFN-beta binds to the same receptor as does HuIFN-alpha 2, identified earlier, and that HuIFN-gamma does not compete with 125I-[Ser17]HuIFN-beta for this receptor. We conclude that HuIFN-gamma interacts with specific receptors that are distinctly different from the receptors recognized by HuIFN-alpha and HuIFN-beta.
用125I标记的纯化重组人γ干扰素(HuIFN-γ,即125I-HuIFN-γ)来研究人WISH细胞上HuIFN-γ的受体。125I-HuIFN-γ与WISH细胞结合,这种结合可被未标记的HuIFN-γ取代,但不能被未标记的重组HuIFN-α2或[Ser17]HuIFN-β(在第17位丝氨酸取代了半胱氨酸的HuIFN-β)取代,这表明存在HuIFN-γ的特异性结合位点。细胞结合的125I-HuIFN-γ用辛二酸二琥珀酰亚胺酯或乙二醇双(琥珀酰亚胺基琥珀酸酯)进行交联,经十二烷基硫酸钠/聚丙烯酰胺凝胶电泳分析,产生了一个相对分子质量约为105,000±5,000的复合物。用未标记的HuIFN-γ而非HuIFN-α2或[Ser17]HuIFN-β预先孵育细胞可阻止该复合物的形成,这表明HuIFN-γ与一种特异性受体分子结合,而HuIFN-α2或HuIFN-β不与该受体相互作用。用125I标记的重组[Ser17]HuIFN-β(125I-[Ser17]HuIFN-β)进行实验以验证这一结论。125I-[Ser17]HuIFN-β与人WISH细胞和Daudi细胞的结合及交联产生了一个相对分子质量约为150,000的复合物,类似于前面所述用125I-HuIFN-α2获得的复合物。未标记的[Ser17]HuIFN-β和HuIFN-α2可取代与125I-[Ser17]HuIFN-β形成的这种相对分子质量为150,000的复合物,但HuIFN-γ不能,这表明[Ser17]HuIFN-β与先前鉴定的HuIFN-α2结合相同的受体,且HuIFN-γ不与125I-[Ser17]HuIFN-β竞争该受体。我们得出结论,HuIFN-γ与特异性受体相互作用,这些受体与HuIFN-α和HuIFN-β所识别的受体明显不同。